AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
SGLT2 Inhibitors - I'm In. Count Me In
"I actually am intrigued. I don't know where it's going to go with the SGLT2 inhibitors, but I do feel inclined that I might reach for one sooner than maybe I have historically," he said. "Maybe it's time we could take a page from the loopist community and start thinking about ferrosemide sparing therapies."